Skip to content

Study held to see the efficacy of an Ayurvedic formulation as an add-on effect in the management of type 2 Diabetes mellitus

A single arm clinical study to evaluate the efficacy of an Ayurvedic formulation as an add-on effect in the management of Prameha(type 2 Diabetes mellitus)

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050867
Enrollment
40
Registered
2023-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

None listed

Sponsors

Neha Suresh Dubal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Selection of patient irrespective of gender, religion and socio-economical status A known Diabetic on treatment or newly diagnosed Diabetes Patients with fasting blood sugar levels >126mg% up to 300mg% and post prandial >200mg% up to 450mg%

Exclusion criteria

Exclusion criteria: Patient who is already taking Ayurvedic management for Prameha Diabetes mellitus type 1 acromegaly cushings syndrome and pancreatic disorder Pregnant and lactating mothers Patients with acute complications like hyperglycemic coma ketoacidosis and infections like gangrene

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Ayurvedic formulation as an add-on effect in lowering blood sugar levels in the management of Prameha(type 2 diabetes mellitus)Timepoint: 28 days study with 2 follow ups(0,14,28)

Secondary

MeasureTime frame
to study new etiological factors in present era To see the adverse effect if any.Timepoint: 28 days study with 2 follow ups(0,14,28)

Countries

India

Contacts

Public ContactNeha Suresh Dubal

Dr.D.Y.Patil college of Ayurved and research center

drdgdipankar@gmail.com9822279321

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026